Pazonat 200mg tablet is a antineoplastic medicine used to treat Kidney cancer & Soft tissue sarcoma. As a tyrosine kinase inhibitor it works to control the growth & spread of cancer cells reducing tumor’s blood supply and slowing cancer cell multiplication. Pazonat 200mg tablet is prescribed as an anticancer drug for the treatment of advanced kidney cancer (renal cell carcinoma) & soft tissue sarcoma).
Pazonat 200mg tablet is used in the treatment of Renal Cell Carcinoma & Soft Tissue Sarcoma (advanced kidney cancer). Pazonat 200mg tablet works by blocking several biomolecules involved in the growth and proliferation of tumor cells.
This is the most common type of kidney cancer in adults, caused by uncontrolled cell division in the small tubes in the kidney. This disease generally does not produce any symptoms initially. However, it can metastasize and spread to surrounding organs like the lungs, bones, and liver. Pazonat 200mg tablet works by targeting the tumor’s blood supply, thus weakening it and preventing it from growing any further.
This is a rare type of cancer that arises from connective tissues in the body, such as nerves, blood vessels, muscles, fat tissues, etc. These types of cancers often grow aggressively and can be recurring. If left untreated, this condition can spread rapidly and would be difficult to treat. In this indication, Pazonat 200mg tablet controls the growth and spread of the tumor and improves progression-free survival.
Pazonat 200mg tablet is used to slow down the growth & spread of cancer cells in adult patients with advanced kidney cancer (renal cell carcinoma) & soft tissue sarcoma). Pazonat 200mg tablet works by blocking the signals involved in cancer cell growth & the formation of new blood vessels that feed tumors
The dosage guidelines for both renal cell carcinoma and advanced soft tissue sarcoma are the same. The dosage guidelines for both these indications are explained below:
You can buy Pazonat 200mg tablets from Lifesaving-meds.com at low price online with free shipping & free sample medicines. Lifesaving-meds.com provide Pazonat 200mg at very less wholesale price for sale from India with low price guarantee, big discounts, free delivery, credit card / debit card, Zellepay, paypal, crypto / Bitcoin payment option & more in the United states of America (USA) – New York, California, Texas, Florida, Ohio, Oregon, Georgia, Denver, Illinois, Oregon, Pennsylvania, Washington, Wyoming & more; United Kingdom (UK) – London, Birmingham, Wales, Manchester & more; Europe (EU) – Moscow (Russia), Paris (France), Spain & more; and Australia (AU) – Sydney, Melbourne, Brisbane & more. So, buy Pazonat 200mg tablets near you when you are prescribed with this medication or search as Pazonat 200mg for sale near me on google, bing, yahoo, duckducko, AOL & anywhere.
Pazonat 200mg tablet consists of the active ingredient Pazopanib, which is an antincancer medication, mainly used in the treatment of Renal Cell Carcinoma and Soft Tissue Sarcoma. It helps prevent further growth and control of tumors, thus preventing them from worsening any further.
Tumors in their advanced stages need a consistent blood supply plus nutrient intake for growth and spread. They obtain these components via the development of new networks of blood vessels through angiogenesis (forming new blood vessels). Tumor cells secrete biomolecules called vascular endothelial growth factors (VEGF) that act on receptors found on the blood vessels of surrounding tissues. This triggers the creation of new blood vessels that bring blood supply to them from surrounding areas. The newly formed blood vessels supply blood with oxygen, nutrients, and growth factor(s) for the growth of the tumor.
Pazonat 200mg tablet inhibits the action of these VEGFs, including the receptors for each of the three types of VEGFs involved in tumor angiogenesis - VEGFR-1, VEGFR-2, and VEGFR-3. By inhibiting the activities of these three factors, Pazonat 200mg tablet interrupts the process that is critical to malignant tumor growth and spread by starving them of supplies required for survival and replication.
Pazonat 200mg tablet not only inhibits VEGF but also other significant proliferation and survival factor receptors such as PDGRF-α, PDGFR-β, and c-KIT, which are critical to the cells’ ability to migrate, survive, and divide. Thus, the inhibition of growth and division factors ultimately leads to a reduction of cancer cell growth rates. Inhibiting the pathways induced by these receptors also inhibits other pathways dependent on these same receptors, which include the MAPK and PI3K-AKT pathways.
By stabilizing the abnormal vasculature of tumours and reducing vascular permeability, Pazonat 200mg tablet also influences the tumour microenvironment, and therefore limits the invasion of the tumour and metastasis. Overall, Pazonat 200 slows the progression of disease and promotes the gradual control of tumour size, rather than eradicating all cancer cells. Although there may still be negative impacts on healthy cells dependent on these signalling pathways, this targeted manner encourages a more specific effect upon cancer-related pathways.
These side effects require immediate medical attention:
Pazonat 200mg tablet must be consumed only if recommended by a licensed healthcare provider or an oncologist.
As there is a risk of severe hepatotoxicity associated with Pazonat 200mg tablet, liver function needs to be regularly monitored. Patients should report any symptoms like yellowing of the eyes or skin, dark urine, fatigue, or abdominal pain immediately.
While on Pazonat 200 therapy, there must be regular monitoring of blood pressure as the medication can cause severe hypertension.
Patients suffering from heart diseases should use it with caution as it may result in QT prolongation, irregular heartbeats, or other cardiac complications.
Pazonat 200mg tablet can increase the risk of blood clots (DVT, pulmonary embolism, stroke). Hence, doctors must consider carefully before administering this medication to susceptible patients.
If there are any signs of infection, such as fever or sore throat, patients must immediately report them to their doctors.
Pazonat 200mg tablet must be consumed cautiously by patients with liver disease, kidney disease, heart disorders, bleeding disorders, clotting disorders, uncontrolled hypertension, or gastrointestinal conditions.
Pazota 200 is not intended to be used by pregnant women, as it can affect the developing fetus.
Pazonat 200mg tablet is contraindicated with certain other drugs, such as CYP3A4 inhibitors/inducers. Hence, patients must inform their healthcare providers about any ongoing medications or herbal supplements.
While on Pazolat 200 therapy, there must be regular monitoring of liver tests, BP, ECG, thyroid function, urine protein, etc.
Pazolat 200 is associated (rarely) with certain neurological symptoms such as headache, confusion, seizures, or vision changes. If patients observe any such symptoms, they must immediately report these symptoms to their healthcare providers.
As Pazonat 200 tablet affects the wound healing factors, it is important to report the consumption of this drug before any surgeries. The consumption of this medication must be stopped at least 7 days before the scheduled surgery.
Apart from this, patients must report any other unusual symptoms or seek emergency care if required.
Pazonat 200 tablet works by inhibiting the supply of blood, nutrients, and growth factors to the tumor, thus preventing its growth.
Pazonat 200 tablet is used in the treatment of Renal Cell Carcinoma and Soft Tissue Sarcoma.
No. Pazonat 200 tablet must be consumed on an empty stomach, at least 1 hour before or 2 hours after food consumption.
If patients experience any symptoms such as yellowing of the skin, severe fatigue, bleeding, or chest pain, they must immediately seek medical attention.
Pazonat 200 tablet must not be consumed by breastfeeding women, as there is no research available on whether it passes into breastmilk.
